Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical Etanercept via Laser Microporation in Psoriasis
NCT02999776Phase 1Unknown
- Sponsor
- Pantec Biosolutions AG
- Start
- Nov 2016
- Primary completion
- Dec 2017
- Modality
- Fc-Fusion Proteins
- Countries
- 1
01
Overview
Phase 1, randomised, single-blind trial of etanercept in plaque psoriasis (3 arms), sponsored by Pantec Biosolutions AG. Primary endpoint: Administration site reactions at 8 weeks. Status: unknown.
02
Drugs
etanercept
03
Conditions
plaque psoriasis
Beyond the preview
Go deeper on NCT02999776.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02999776.